Facts & Data

Facts and data to help you understand brain and eye disease.

What can we help you find?

    Clear all
  • Fact Sheet

    Clinical Trial Information for Macular Degeneration

    It can take many years for a potential treatment for macular degeneration to work its way from the laboratory, through rigorous testing and, finally, to become approved by the U.S. Food and Drug Administration (FDA). Learn more about the process and how clinical trials work.

    April 15, 2016
  • Fact Sheet

    Clinical Trial Information for Alzheimer's Disease

    It can take many years for a potential treatment for Alzheimer's disease to work its way from the laboratory, through rigorous testing and, finally, to become approved by the U.S. Food and Drug Administration (FDA). Learn more about the process and how clinical trials work.

    February 1, 2016
  • Fact Sheet

    Clinical Trial Information for Glaucoma

    It can take many years for a potential treatment for glaucoma to work its way from the laboratory, through rigorous testing and, finally, to become approved by the U.S. Food and Drug Administration (FDA). Learn more about the process and how clinical trials work.

    March 14, 2016
  • Fact Sheet

    Alzheimer’s Disease: Facts & Figures

    Every 65 seconds, someone in America develops Alzheimer's. It is estimated that nearly 500,000 new cases of Alzheimer's disease will be diagnosed this year. Get the facts about Alzheimer's disease—the most common form of dementia.

    February 7, 2017

  • Normal brain vs. Alzheimer's brain

    Take a look at the formation of amyloid plaques in a brain affected by Alzheimer's compared to a normal brain.
    View Infographic
  • Fact Sheet

    Macular Degeneration: Frequently Asked Questions

    Age-related macular degeneration (AMD) is a common eye disease that causes deterioration of the macula, the central area of the retina. Read the answers to the most frequently asked questions about this eye disease.

    March 1, 2016
  • Fact Sheet

    Glaucoma Treatments

    The most common treatments for glaucoma are eye drops and, rarely, pills. If you are using these medications. be aware of their purpose and potential side effects, which should be explained by a medical professional.

    January 11, 2018
    • Don't miss out.
    Receive research updates, inspiring stories, and expert advice
    Keep me informed about: *
    Please select at least one.
    You must select at least one disease category.
    Please enter your first name.
    Please enter your last name.

    Join us in the fight to end brain and eye disease

    • 1 in 16 Americans over age 40 has either Alzheimer's, macular degeneration, or glaucoma.

    • BrightFocus has funded more than $190 million in groundbreaking research to eradicate brain and eye disease. 

    • BrightFocus makes innovative science possible around the world—1,456 research projects involving more than 4,659 scientists in 22 countries. 

    • You can make a difference. 
      Support BrightFocus-funded research to end brain and eye diseases in our lifetime.

      Give Now